Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
All cancer types
Closed
Phase 1
This trial is looking at a new drug called RO5126766 to treat solid tumours and a type of cancer called myeloma. It is for people with a or myeloma who have no options available to them.
Recruitment start: 21 May 2013
Recruitment end: 26 September 2016
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Udai Banerji
Experimental Cancer Medicine Centre (ECMC)
Institute of Cancer Research (ICR)
Royal Marsden NHS Foundation Trust
Last reviewed: 18 Jan 2017
CRUK internal database number: 11701